JINDUN Medical Showcases Comprehensive Pharmaceutical Solutions at CPhI Europe 2025
2025-11-14
JINDUN Medical Showcases Comprehensive Pharmaceutical Solutions at CPhI Europe 2025, Empowering Global Healthcare Innovation
JINDUN Medical, a trusted provider of high-quality Active Pharmaceutical Ingredients (APIs), intermediates, and empty capsules, proudly participated in the CPhI Europe 2025 exhibition held at Messe Frankfurt from October 28–30, 2025. As a premier event in the pharmaceutical industry, CPhI Europe 2025 brought together global leaders, innovators, and decision-makers to explore cutting-edge solutions and collaborative opportunities.
At the exhibition, JINDUN Medical highlighted its diverse product portfolio, including innovative APIs for oncology, cardiovascular, and rare diseases; high-purity intermediates for streamlined drug synthesis; and meticulously crafted empty capsules for enhanced drug delivery. Our company emphasized its commitment to excellence in quality, safety, and sustainability, aligning with industry trends toward green chemistry and smart manufacturing.
JINDUN Medical engaged with international partners, including pharmaceutical manufacturers, distributors, and research institutions, fostering dialogue on expanding market reach and co-developing tailored healthcare solutions. The company’s participation underscored its dedication to driving innovation in the pharmaceutical sector and strengthening global supply chain partnerships.
By showcasing its comprehensive pharmaceutical solutions, JINDUN Medical reaffirmed its position as a reliable partner in delivering high-quality raw materials to meet the evolving needs of the global healthcare industry.










Hot Tags:
PREVIOUS: